Trials / Completed
CompletedNCT02462005
Treatment of Femoro-popliteal Atherosclerotic Lesions Using the Ranger Paclitaxel Coated Balloon Catheter. All Comers Registry.
Ranger DEB All Comers Registry - Treatment of Femoro-popliteal Atherosclerotic Lesions Using the Ranger Paclitaxel Coated Balloon Catheter: An All Comers Registry.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 171 (actual)
- Sponsor
- Klinikum Arnsberg · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A total of up to 250 patients from an all-comers patient population with infrainguinal atherosclerotic disease who are implanted or scheduled for an implant with a Ranger Drug coated balloon. Interim analysis will be carried out for every 50 subjects enrolled.
Conditions
Timeline
- Start date
- 2015-02-01
- Primary completion
- 2018-06-01
- Completion
- 2019-05-01
- First posted
- 2015-06-03
- Last updated
- 2020-01-09
Locations
6 sites across 2 countries: Germany, Switzerland
Source: ClinicalTrials.gov record NCT02462005. Inclusion in this directory is not an endorsement.